These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 21783359

  • 1. 2-Phenyl and 2-heterocyclic-4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridines as inhibitors of TGF-β1 and activin A signalling.
    Ciayadi R, Potdar M, Walton KL, Harrison CA, Kelso GF, Harris SJ, Hearn MT.
    Bioorg Med Chem Lett; 2011 Sep 15; 21(18):5642-5. PubMed ID: 21783359
    [Abstract] [Full Text] [Related]

  • 2. Synthesis, antibacterial, and antiviral evaluation of new heterocycles containing the pyridine moiety.
    Salem MS, Sakr SI, El-Senousy WM, Madkour HM.
    Arch Pharm (Weinheim); 2013 Oct 15; 346(10):766-73. PubMed ID: 24105721
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of basic, heterocyclic ring systems as templates for use as potassium competitive acid blockers (pCABs).
    Panchal T, Bailey N, Bamford M, Demont E, Elliott R, Farre-Gutierrez I, Garton N, Hayhow T, Hutley G, Naylor A.
    Bioorg Med Chem Lett; 2009 Dec 01; 19(23):6813-7. PubMed ID: 19846298
    [Abstract] [Full Text] [Related]

  • 4. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
    Baraldi PG, Tabrizi MA, Preti D, Bovero A, Romagnoli R, Fruttarolo F, Zaid NA, Moorman AR, Varani K, Gessi S, Merighi S, Borea PA.
    J Med Chem; 2004 Mar 11; 47(6):1434-47. PubMed ID: 14998332
    [Abstract] [Full Text] [Related]

  • 5. Identification of protein binding partners of ALK-5 kinase inhibitors.
    Ciayadi R, Kelso GF, Potdar MK, Harris SJ, Walton KL, Harrison CA, Hearn MT.
    Bioorg Med Chem; 2013 Nov 01; 21(21):6496-500. PubMed ID: 24055074
    [Abstract] [Full Text] [Related]

  • 6. General and modular synthesis of isomeric 5-substituted pyridin-2-yl and 6-substituted pyridin-3-yl C-ribonucleosides bearing diverse alkyl, aryl, hetaryl, amino, carbamoyl, and hydroxy groups.
    Štefko M, Slavětínská L, Klepetářová B, Hocek M.
    J Org Chem; 2011 Aug 19; 76(16):6619-35. PubMed ID: 21739971
    [Abstract] [Full Text] [Related]

  • 7. Discovery of 4-{4-[3-(pyridin-2-yl)-1H-pyrazol-4-yl]pyridin-2-yl}-N-(tetrahydro-2H- pyran-4-yl)benzamide (GW788388): a potent, selective, and orally active transforming growth factor-beta type I receptor inhibitor.
    Gellibert F, de Gouville AC, Woolven J, Mathews N, Nguyen VL, Bertho-Ruault C, Patikis A, Grygielko ET, Laping NJ, Huet S.
    J Med Chem; 2006 Apr 06; 49(7):2210-21. PubMed ID: 16570917
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of gene markers of fibrosis with a novel inhibitor of transforming growth factor-beta type I receptor kinase in puromycin-induced nephritis.
    Grygielko ET, Martin WM, Tweed C, Thornton P, Harling J, Brooks DP, Laping NJ.
    J Pharmacol Exp Ther; 2005 Jun 06; 313(3):943-51. PubMed ID: 15769863
    [Abstract] [Full Text] [Related]

  • 9. Activin A inhibits growth-inhibitory signals by TGF-beta1 in differentiated human endometrial adenocarcinoma cells.
    Tanaka T, Toujima S, Umesaki N.
    Oncol Rep; 2004 Apr 06; 11(4):875-9. PubMed ID: 15010888
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and biological evaluation of 5-(pyridin-2-yl)thiazoles as transforming growth factor-beta type1 receptor kinase inhibitors.
    Kim DK, Choi JH, An YJ, Lee HS.
    Bioorg Med Chem Lett; 2008 Mar 15; 18(6):2122-7. PubMed ID: 18262787
    [Abstract] [Full Text] [Related]

  • 11. (1H-imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: further optimisation as highly potent and selective MSK-1-inhibitors.
    Bamford MJ, Bailey N, Davies S, Dean DK, Francis L, Panchal TA, Parr CA, Sehmi S, Steadman JG, Takle AK, Townsend JT, Wilson DM.
    Bioorg Med Chem Lett; 2005 Jul 15; 15(14):3407-11. PubMed ID: 15955699
    [Abstract] [Full Text] [Related]

  • 12. Design, synthesis and structure-activity relationship study of novel pyrazole-based heterocycles as potential antitumor agents.
    Farag AM, Ali KA, El-Debss TM, Mayhoub AS, Amr AG, Abdel-Hafez NA, Abdulla MM.
    Eur J Med Chem; 2010 Dec 15; 45(12):5887-98. PubMed ID: 20950898
    [Abstract] [Full Text] [Related]

  • 13. Novel derivatives of 2-pyridinemethylamine as selective, potent, and orally active agonists at 5-HT1A receptors.
    Vacher B, Bonnaud B, Funes P, Jubault N, Koek W, Assié MB, Cosi C, Kleven M.
    J Med Chem; 1999 May 06; 42(9):1648-60. PubMed ID: 10229633
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and biological evaluation of imidazo[1,2-a]pyridine derivatives as novel PI3 kinase p110alpha inhibitors.
    Hayakawa M, Kaizawa H, Kawaguchi K, Ishikawa N, Koizumi T, Ohishi T, Yamano M, Okada M, Ohta M, Tsukamoto S, Raynaud FI, Waterfield MD, Parker P, Workman P.
    Bioorg Med Chem; 2007 Jan 01; 15(1):403-12. PubMed ID: 17049248
    [Abstract] [Full Text] [Related]

  • 15. Discovery and initial SAR of 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-ones as inhibitors of insulin-like growth factor 1-receptor (IGF-1R).
    Velaparthi U, Wittman M, Liu P, Stoffan K, Zimmermann K, Sang X, Carboni J, Li A, Attar R, Gottardis M, Greer A, Chang CY, Jacobsen BL, Sack JS, Sun Y, Langley DR, Balasubramanian B, Vyas D.
    Bioorg Med Chem Lett; 2007 Apr 15; 17(8):2317-21. PubMed ID: 17317169
    [Abstract] [Full Text] [Related]

  • 16. A facile iodine(III)-mediated synthesis of 3-(3-aryl-1-phenyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-a]pyridines via oxidation of 2-((3-aryl-1-phenyl-1H-pyrazol-4-yl)methylene)-1-(pyridin-2-yl)hydrazines and their antimicrobial evaluations.
    Prakash O, Hussain K, Aneja DK, Sharma C, Aneja KR.
    Org Med Chem Lett; 2011 Jul 18; 1(1):1. PubMed ID: 22373059
    [Abstract] [Full Text] [Related]

  • 17. Pioglitazone induces apoptosis in human vascular smooth muscle cells from diabetic patients involving the transforming growth factor-beta/activin receptor-like kinase-4/5/7/Smad2 signaling pathway.
    Ruiz E, Redondo S, Gordillo-Moscoso A, Tejerina T.
    J Pharmacol Exp Ther; 2007 May 18; 321(2):431-8. PubMed ID: 17267584
    [Abstract] [Full Text] [Related]

  • 18. Structure-activity relationships of adenosines with heterocyclic N6-substituents.
    Ashton TD, Aumann KM, Baker SP, Schiesser CH, Scammells PJ.
    Bioorg Med Chem Lett; 2007 Dec 15; 17(24):6779-84. PubMed ID: 17967536
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and antiproliferative activity in vitro of new pyrido[1,4-b]diazepine derivatives and imidazo[4,5-b]pyridine.
    Liszkiewicz H, Nawrocka WP, Sztuba B, Wietrzyk J, Jaroszewicz J, Nasulewicz A, Pełczyńska M.
    Acta Pol Pharm; 2011 Dec 15; 68(3):349-55. PubMed ID: 21648189
    [Abstract] [Full Text] [Related]

  • 20. TGF-β1/ALK5-induced monocyte migration involves PI3K and p38 pathways and is not negatively affected by diabetes mellitus.
    Olieslagers S, Pardali E, Tchaikovski V, ten Dijke P, Waltenberger J.
    Cardiovasc Res; 2011 Aug 01; 91(3):510-8. PubMed ID: 21478266
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.